Orlistat
Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet
Empros Pharma AB · Phase 2 · Completed · Enrollment 486
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.